Over 2,100 oncology clinical trials initiated globally in 2024, with targeted therapies as fastest growing, over 100...
Posted by Oncolytics Biotech Inc. based in Vancouver, BC on February 17, 2026, Equity-Insider.com News Commentary states that in 2024, a total of 2,100 oncology clinical trials were launched worldwide. Among these, targeted therapies emerged as the most rapidly expanding subcategory, with over 100 trials conducted in this area.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments